The biology of pneumolysin

Sub-Cellular Biochemistry

Volumn 80, Issue , 2014, Pages 145-160

  Mitchell, Tim J ^a   Dalziel, Catherine E ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cell death; Human respiratory epithelium; Meningitis; Pathogenesis of pneumococcal infection; Pneumolysin; Streptococcus pneumoniae

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEIN; BACTERIAL VACCINE; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ANIMAL; CELL DEATH; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL VACCINES; CELL DEATH; HUMANS; IMMUNE SYSTEM; INFLAMMATION; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84906313204     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-017-8881-6_8     Document Type: Article

References (82)

1. Alcantara RB, Preheim LC, Gentry MJ (1999) Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Infect Immun 67: 2862-2866.
2. Alcantara RB, Preheim LC, Gentry-Nielsen MJ (2001) Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia. Infect Immun 69: 3569-3575.
3. Alexander JE, Lock RA, Peeters CC, Poolman JT, Andrew PW, Mitchell TJ, Hansman D, Paton JC (1994) Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun 62: 5683-5688.
4. Asbell P, Stenson S (1982) Ulcerative keratitis. Survey of 30 years' laboratory experience. Arch Ophthalmol 100: 77-80.
5. Badwey JA, Curnutte JT, Robinson JM, Berde CB, Karnovsky MJ, Karnovsky ML (1984) Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin. J Biol Chem 259: 7870-7877.
6. Balachandran P, Hollingshead SK, Paton JC, Briles DE (2001) The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol 183: 3108-3116.
7. Benton KA, Everson MP, Briles DE (1995) A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun 63: 448-455.
8. Berry AM, Yother J, Briles DE, Hansman D, Paton JC (1989) Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect Immun 57: 2037-2042.
9. Beurg M, Hafidi A, Skinner L, Cowan G, Hondarrague Y, Mitchell TJ, Dulon D (2005) The mechanism of pneumolysin-induced cochlear hair cell death in the rat. J Physiol 568: 211-227.
10. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, Florquin S, van der Poll T (2004) Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infect Immun 72: 788-794.
11. Braun JS, Novak R, Gao G, Murray PJ, Shenep JL (1999) Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 67: 3750-3756.
12. Braun JS, Sublett JE, Freyer D, Mitchell TJ, Cleveland JL, Tuomanen EI, Weber JR (2002) Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest 109: 19-27.
13. Canvin JR, Marvin AP, Sivakumaran M, Paton JC, Boulnois GJ, Andrew PW, Mitchell TJ (1995) The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J Infect Dis 172: 119-123.
14. Chu J, Thomas LM, Watkins SC, Franchi L, Nunez G, Salter RD (2009) Cholesteroldependent cytolysins induce rapid release of mature IL-1beta from murine macrophages in a NLRP3 inflammasome and cathepsin B-dependent manner. J Leukoc Biol 86: 1227-1238.
15. Cockeran R, Durandt C, Feldman C, Mitchell TJ, Anderson R (2002) Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis 186: 562-565.
16. Cockeran R, Steel HC, Mitchell TJ, Feldman C, Anderson R (2001) Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect Immun 69: 3494-3496.
17. Cockeran R, Theron AJ, Steel HC, Matlola NM, Mitchell TJ, Feldman C, Anderson R (2001) Proinflammatory interactions of pneumolysin with human neutrophils. J Infect Dis 183: 604-611.
18. Curnutte JT, Badwey JM, Robinson JM, Karnovsky MJ, Karnovsky ML (1984) Studies on the mechanism of superoxide release from human neutrophils stimulated with arachidonate. J Biol Chem 259: 11851-11857.
19. Dessing MC, Hirst RA, de Vos AF, van der Poll T (2009) Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice. PLoS One 4: e7993.
20. Dockrell DH, Lee M, Lynch DH, Read RC (2001) Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J Infect Dis 184: 713-722.
21. Douce G, Ross K, Cowan G, Ma J, Mitchell TJ (2010) Novel mucosal vaccines generated by genetic conjugation of heterologous proteins to pneumolysin (PLY) from Streptococcus pneumoniae. Vaccine 28: 3231-3237.
22. Feldman C, Mitchell TJ, Andrew PW, Boulnois GJ, Read RC, Todd HC, Cole PJ, Wilson R (1990) The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathog 9: 275-284.
23. Ferrante A, RowanKelly B, Paton JC (1984) Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin. Infect Immun 46: 585-589.
24. Fortsch C, Hupp S, Ma J, Mitchell TJ, Maier E, Benz R, Iliev AI (2011) Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity. Toxins (Basel) 3: 43-62.
25. Giebink GS, Dee TH, Kim Y, Quie PG (1980) Alterations in serum opsonic activity and complement levels in pneumococcal disease. Infect Immun 29: 1062-1066.
26. Goulart C, da Silva TR, Rodriguez D, Politano WR, Leite LC, Darrieux M (2013) Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives. PLoS One 8: e59605.
27. Hamon MA, Batsche E, Regnault B, Tham TN, Seveau S, Muchardt C, Cossart P (2007) Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci USA 104: 13467-13472.
28. Hirst RA, Mohammed BJ, Mitchell TJ, Andrew PW, O'Callaghan C (2004) Streptococcus pneumoniae-induced inhibition of rat ependymal cilia is attenuated by antipneumolysin antibody. Infect Immun 72: 6694-6698.
29. Hirst RA, Yesilkaya H, Clitheroe E, Rutman A, Dufty N, Mitchell TJ, O'Callaghan C, Andrew PW (2002) Sensitivities of human monocytes and epithelial cells to pneumolysin are different. Infect Immun 70: 1017-1022.
30. Hupp S, Fortsch C, Wippel C, Ma J, Mitchell TJ, Iliev AI (2013) Direct transmembrane interaction between actin and the pore-competent, cholesterol-dependent cytolysin pneumolysin. J Mol Biol 425: 636-646.
31. Iliev AI, Djannatian JR, Nau R, Mitchell TJ, Wouters FS (2007) Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin. Proc Natl Acad Sci USA 104: 2897-2902.
32. Iliev AI, Djannatian JR, Opazo F, Gerber J, Nau R, Mitchell TJ, Wouters FS (2009) Rapid microtubule bundling and stabilization by the Streptococcus pneumoniae neurotoxin pneumolysin in a cholesterol-dependent, non-lytic and Src-kinase dependent manner inhibits intracellular trafficking. Mol Microbiol 71: 461-477.
33. Jarva H, Jokiranta TS, Wurzner R, Meri S (2003) Complement resistance mechanisms of streptococci. Mol Immunol 40: 95-107.
34. Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, Smith A, Clarke SC, Brueggemann AB, George RC, Pichon B, Pluschke G, Pfluger V, Mitchell TJ (2007) Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis 196: 936-944.
35. Johnson MK, Hobden JA, Hagenah M, OCallaghan RJ, Hill JM, Chen S (1990) The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res 9: 1107-1114.
36. Kadioglu A, Gingles NA, Grattan K, Kerr A, Mitchell TJ, Andrew PW (2000) Host cellular immune response to pneumococcal lung infection in mice. Infect Immun 68: 492-501.
37. Kadioglu A, Taylor S, Iannelli F, Pozzi G, Mitchell TJ, Andrew PW (2002) Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun 70: 2886-2890.
38. Kamtchoua T, Bologa M, Hopfer R, Neveu D, Hu B, Sheng X, Corde N, Pouzet C, Zimmermann G, Gurunathan S (2013) Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults. Vaccine 31: 327-333.
39. Kerr AR, Paterson GK, Riboldi-Tunnicliffe A, Mitchell TJ (2005) Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun 73: 4245-4252.
40. Kirkham LA, Jefferies JM, Kerr AR, Jing Y, Clarke SC, Smith A, Mitchell TJ (2006) Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol 44: 151-159.
41. Kirkham LA, Kerr AR, Douce GR, Paterson GK, Dilts DA, Liu DF, Mitchell TJ (2006) Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines. Infect Immun 74: 586-593.
42. Lim JH, Stirling B, Derry J, Koga T, Jono H, Woo CH, Xu H, Bourne P, Ha UH, Ishinaga H, Andalibi A, Feng XH, Zhu H, Huang Y, Zhang W, Weng X, Yan C, Yin Z, Briles DE, Davis RJ, Flavell RA, Li JD (2007) Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity 27: 349-360.
43. Lock RA, Zhang QY, Berry AM, Paton JC (1996) Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretc mobility of the toxin. Microb Pathogen 21: 71-83.
44. Lucas R, Yang G, Gorshkov BA, Zemskov EA, Sridhar S, Umapathy NS, Jezierska-Drutel A, Alieva IB, Leustik M, Hossain H, Fischer B, Catravas JD, Verin AD, Pittet JF, Caldwell RB, Mitchell TJ, Cederbaum SD, Fulton DJ, Matthay MA, Caldwell RW, Romero MJ, Chakraborty T (2012) Protein kinase C-alpha and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability. Am J Respir Cell Mol Biol 47: 445-453.
45. Luttge M, Fulde M, Talay SR, Nerlich A, Rohde M, Preissner KT, Hammerschmidt S, Steinert M, Mitchell TJ, Chhatwal GS, Bergmann S (2012) Streptococcus pneumoniae induces exocytosis of Weibel-Palade bodies in pulmonary endothelial cells. Cell Microbiol 14: 210-225.
46. Lysenko ES, Ratner AJ, Nelson AL, Weiser JN (2005) The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog 1: e1.
47. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT (2003) Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 100: 1966-1971.
48. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D, Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, Moran B, Fitzgerald KA, Tschopp J, Petrilli V, Andrew PW, Kadioglu A, Lavelle EC (2010) Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog 6: e1001191.
49. Mitchell TJ, Andrew PW, Saunders FK, Smith AN, Boulnois GJ (1991) Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol 5: 1883-1888.
50. Moreland JG, Bailey G (2006) Neutrophil transendothelial migration in vitro to Streptococcus pneumoniae is pneumolysin dependent. Am J Physiol Lung Cell Mol Physiol 290: L833-L840.
51. Norcross EW, Sanders ME, Moore QC 3rd, Marquart ME (2011) Pathogenesis of a clinical ocular strain of Streptococcus pneumoniae and the interaction of pneumolysin with corneal cells. J Bacteriol Parasitol 2: 108.
52. Orihuela CJ, Gao GL, Francis KP, Yu J, Tuomanen EI (2004) Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 190(9): 1661-1669.
53. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, Ratner AJ, Fitzgerald KA, Schindler C, Prince A (2011) Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2: e00016-e00011.
54. Paton JC, Lock RA, Hansman DJ (1983) Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae. Infect Immun 40: 548-552.
55. Paton JC, Lock RA, Lee CJ, Li JP, Berry AM, Mitchell TJ, Andrew PW, Hansman D, Boulnois GJ (1991) Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide. Infect Immun 59: 2297-2304.
56. Price KE, Greene NG, Camilli A (2012) Export requirements of pneumolysin in Streptococcus pneumoniae. J Bacteriol 194: 3651-3660.
57. Propst-Graham KL, Preheim LC, Vander Top EA, Snitily MU, Gentry-Nielsen MJ (2007) Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae. BMC Microbiol 7: 94.
58. Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser JN (2007) Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol 9: 1343-1351.
59. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL, Weiser JN (2006) Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 281: 12994-12998.
60. Ratner AJ, Lysenko ES, Paul MN, Weiser JN (2005) Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces. Proc Natl Acad Sci USA 102: 3429-3434.
61. Rayner CF, Jackson AD, Rutman A, Dewar A, Mitchell TJ, Andrew PW, Cole PJ, Wilson R (1995) Interaction of pneumolysin-sufficient and-deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun 63: 442-447.
62. Rayner CFJ, Jackson AD, Rutman A, Dewar A, Mitchell TJ, Andrew PW, Cole PJ, Wilson R (1995) Interaction of Pneumolysin-sufficient and-deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa. Infect Immun 63: 442-447.
63. Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P (2010) Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 464: 1192-1195.
64. Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo E, McDaniel LS (2003) Pneumolysin-dependent and-independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun 71: 2087-2094.
65. Rossjohn J, Gilbert RJ, Crane D, Morgan PJ, Mitchell TJ, Rowe AJ, Andrew PW, Paton JC, Tweten RK, Parker MW (1998) The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J Mol Biol 284(2): 449-461.
66. Rubins JB, Charboneau D, Paton JC, Mitchell TJ, Andrew PW, Janoff EN (1995) Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 95: 142-150.
67. Rubins JB, Duane PG, Charboneau D, Janoff EN (1992) Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun 60: 1740-1746.
68. Rubins JB, Mitchell TJ, Andrew PW, Niewoehner DE (1994) Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infect Immun 62: 3829-3836.
69. Rubins JB, Paddock AH, Charboneau D, Berry AM, Paton JC, Janoff EN (1998) Pneumolysin in pneumococcal adherence and colonization. Microb Pathog 25: 337-342.
70. Sanders ME, Norcross EW, Moore QC 3rd, Fratkin J, Thompson H, Marquart ME (2010) Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis. J Ocul Pharmacol Ther 26: 571-577.
71. Srivastava A, Henneke P, Visintin A, Morse SC, Martin V, Watkins C, Paton JC, Wessels MR, Golenbock DT, Malley R (2005) The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 73: 6479-6487.
72. Steinfort C, Wilson R, Mitchell T, Feldman C, Rutman A, Todd H, Sykes D, Walker J, Saunders K, Andrew PW, Boulnois GJ, Cole PJ (1989) Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun 57: 2006-2013.
73. Stringaris AK, Geisenhainer J, Bergmann F, Balshusemann C, Lee U, Zysk G, Mitchell TJ, Keller BU, Kuhnt U, Gerber J, Spreer A, Bahr M, Michel U, Nau R (2002) Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis 11: 355-368.
74. Tilley SJ, Orlova EV, Gilbert RJ, Andrew PW, Saibil HR (2005) Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121: 247-256.
75. Walker JA, Allen RL, Falmagne P, Johnson MK, Boulnois GJ (1987) Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun 55: 1184-1189.
76. Winter AJ, Comis SD, Osborne MP, Tarlow MJ, Stephen J, Andrew PW, Hill J, Mitchell TJ (1997) A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs. Infect Immun 65: 4411-4418.
77. Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K, Mitchell TJ, de los Toyos JR, Rosseau S, Suttorp N, Schutte H (2006) Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med 34: 1947-1954.
78. Witzenrath M, Gutbier B, Owen JS, Schmeck B, Mitchell TJ, Mayer K, Thomas MJ, Ishii S, Rosseau S, Suttorp N, Schutte H (2007) Role of platelet-activating factor in pneumolysininduced acute lung injury. Crit Care Med 35: 1756-1762.
79. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B (2011) The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187: 434-440.
80. Yuste J, Botto M, Paton JC, Holden DW, Brown JS (2005) Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia. J Immunol 175: 1813-1819.
81. Zysk G, Bejo L, Schneider-Wald BK, Nau R, Heinz H (2000) Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae. Clin Exp Immunol 122: 61-66.
82. Zysk G, Schneider-Wald BK, Hwang JH, Bejo L, Kim KS, Mitchell TJ, Hakenbeck R, Heinz HP (2001) Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect Immun 69: 845-852.